Tumor Paint

Blaze Bioscience Inc.Request Info
Facebook X LinkedIn Email
Blaze Bioscience Inc. has announced the BLZ-100 tumor paint for real-time, high-resolution, intraoperative visualization of cancer cells.

The product consists of an optimized peptide and a fluorescent dye, emitting light in the NIR range for more precise, complete resection of cancer throughout surgery.

The investigative agent is in Phase 1 trials, with preclinical utility demonstrated on a range of cancer types.

Published: February 2016
* First Name:
* Last Name:
* Email Address:
* Company:
* Country:

When you click "Send Request", we will record and send your personal contact information to Blaze Bioscience Inc. by email so they may respond directly. You also agree that Photonics Media may contact you with information related to this inquiry, and that you have read and accept our Privacy Policy and Terms and Conditions of Use.

Register or login to auto-populate this form:
Login Register
* Required

Productsfluorescent tumor agentBLZ-100tumor paintBlazeAmericasBiophotonicsImagingdiagnosticscancerSeattleWashington

We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.